StockDrifts LogoStockDrifts

Tang Capital Management 13F Portfolio ยท Kevin Tang

Portfolio Manager
Kevin Tang
Performance
+10.83% (2026 Q2)
AUM (13F)
$2.20B
# of Holdings
41
Performance Rank
Allocation (Top 20)
88.83%
Latest filing
Q2 2026

Tang Capital Management LLC Holdings Map

Top 40 Tang Capital Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
AUPH
AURINIA PHARMACEUTICALS INC
10.05%13.04M$221.4M
+6.66%(+814.61K)
2025-Q2: 10.03M shares2025-Q3: 11.33M shares2025-Q4: 11.33M shares2026-Q1: 12.23M shares2026-Q2: 13.04M shares
$8.49(+82.17%)
2026-06-30
SYRE
SPYRE THERAPEUTICS INC
7.63%1.89M$168.0M
+0.00%(+0)
2025-Q2: 3.20M shares2025-Q3: 3.20M shares2025-Q4: 1.89M shares2026-Q1: 1.89M shares2026-Q2: 1.89M shares
$18.54(+458.99%)
2026-06-30
MIRM
MIRUM PHARMACEUTICALS INC
6.57%1.24M$144.7M
+0.00%(+0)
2025-Q2: 1.24M shares2025-Q3: 1.24M shares2025-Q4: 1.24M shares2026-Q1: 1.24M shares2026-Q2: 1.24M shares
$26.52(+279.55%)
2026-06-30
KNSA
KINIKSA PHARMACEUTICALS INTL
6.56%2.26M$144.5M
+0.00%(+0)
2025-Q2: 2.33M shares2025-Q3: 2.33M shares2025-Q4: 2.26M shares2026-Q1: 2.26M shares2026-Q2: 2.26M shares
$19.08(+302.21%)
2026-06-30
CELC
CELCUITY INC
6.25%1.31M$137.5M
+25.20%(+264.59K)
2025-Q2: 0 shares2025-Q3: 1.15M shares2025-Q4: 1.05M shares2026-Q1: 1.05M shares2026-Q2: 1.31M shares
$46.48(+97.91%)
2026-06-30
CORT
CORCEPT THERAPEUTICS INC
5.92%1.50M$130.4M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 156.8K shares2026-Q1: 1.50M shares2026-Q2: 1.50M shares
$39.79(+187.67%)
2026-06-30
PTCT
PTC THERAPEUTICS INC
5.56%1.50M$122.4M
+0.00%(+0)
2025-Q2: 1.10M shares2025-Q3: 1.50M shares2025-Q4: 1.50M shares2026-Q1: 1.50M shares2026-Q2: 1.50M shares
$39.40(+83.68%)
2026-06-30
GLPG
LAKEFRONT BIOTHERAPEUTICS NV
5.16%3.79M$113.5M
+0.00%(+0)
2025-Q2: 3.99M shares2025-Q3: 4.15M shares2025-Q4: 3.92M shares2026-Q1: 3.79M shares2026-Q2: 3.79M shares
$27.66(+0.98%)
2026-06-30
CAPR
CAPRICOR THERAPEUTICS INC
4.48%4.10M$98.7M
+20.59%(+700.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.70M shares2026-Q1: 3.40M shares2026-Q2: 4.10M shares
$24.07(-72.37%)
2026-06-30
TARS
TARSUS PHARMACEUTICALS INC
4.48%1.57M$98.7M
+31.94%(+379.64K)
2025-Q2: 2.45M shares2025-Q3: 2.45M shares2025-Q4: 1.19M shares2026-Q1: 1.19M shares2026-Q2: 1.57M shares
$30.79(+124.77%)
2026-06-30

About Tang Capital Management LLCโ€™s portfolio

Tang Capital Management LLC reports $2.20B in US-listed equity holdings across 41 positions in its most recent 13F filing. Its largest disclosed positions are AUPH (10.1%), SYRE (7.6%) and MIRM (6.6%). The top 20 holdings account for 88.83% of reported assets. Its disclosed equity book has returned +72.02% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
AUPH โ€” 10.1% ($221.36M)SYRE โ€” 7.7% ($167.99M)MIRM โ€” 6.6% ($144.70M)KNSA โ€” 6.6% ($144.52M)CELC โ€” 6.3% ($137.53M)CORT โ€” 6.0% ($130.43M)PTCT โ€” 5.6% ($122.36M)GLPG โ€” 5.2% ($113.50M)CAPR โ€” 4.5% ($98.73M)TARS โ€” 4.5% ($98.71M)Other โ€” 37.0% ($810.50M)
63%in top 10
  • AUPH10.1%
  • SYRE7.7%
  • MIRM6.6%
  • KNSA6.6%
  • CELC6.3%
  • CORT6.0%
  • PTCT5.6%
  • GLPG5.2%
  • CAPR4.5%
  • TARS4.5%
  • Other37.0%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
4
NVCTNUVECTIS PHARMA INC1.3%
FULCFULCRUM THERAPEUTICS INC1.1%
NNDMNANO DIMENSION LTD0.9%
BOLDBOUNDLESS BIO INC0.3%
Added to
7
CELCCELCUITY INC+25.2%
TARSTARSUS PHARMACEUTICALS INC+31.9%
CAPRCAPRICOR THERAPEUTICS INC+20.6%
CMPSCOMPASS PATHWAYS PLC+24.9%
+3 more
Trimmed
6
ANABANAPTYSBIO INC-33.3%
SPYSTATE STR SPDR S&P 500 ETF T-26.8%
INSMINSMED INC-61.5%
STOKSTOKE THERAPEUTICS INC-40.0%
+2 more

Unlock alerts, watchlists & AI chat

Sign up free to track Tang Capital Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Tang Capital Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1232621). View Tang Capital Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all